Literature DB >> 14651981

The basic helix-loop-helix transcription factor TAL1/SCL inhibits the expression of the p16INK4A and pTalpha genes.

Anders Hansson1, Christina Manetopoulos, Jan Ingvar Jönsson, Håkan Axelson.   

Abstract

The Tal1 gene (also called Scl or TCL5) encodes a basic helix-loop-helix transcription factor required for hematopoiesis and vasculogenesis. Additionally, aberrant transcriptional activation of the Tal1 gene is a frequent event in human T cell acute lymphoblastic leukemia (T-ALL). T cell specific expression of TAL1 in mice induces aggressive T cell malignancies, demonstrating the oncogenic potential of TAL1. Yet, the underlying mechanisms of TAL1 induced tumorigenesis are poorly understood. By inhibiting E protein mediated transcription of the pTalpha gene, TAL1 can interfere with the T cell differentiation program. In addition, several studies suggest that TAL1 expression might also enhance proliferation rate. We report here that TAL1 can bind the E boxes in both the p16 and the pTalpha promoters, and functionally suppress the activity of both promoters. These results indicate that TAL1 can affect both T cell proliferation and differentiation. Moreover, we show that overexpression of TAL1 in hematopoietic progenitor cells promotes cell cycle division.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14651981     DOI: 10.1016/j.bbrc.2003.11.030

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.

Authors:  Teresa Palomero; Duncan T Odom; Jennifer O'Neil; Adolfo A Ferrando; Adam Margolin; Donna S Neuberg; Stuart S Winter; Richard S Larson; Wei Li; X Shirley Liu; Richard A Young; A Thomas Look
Journal:  Blood       Date:  2006-04-18       Impact factor: 22.113

2.  Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis.

Authors:  Y Li; C Deng; X Hu; B Patel; X Fu; Y Qiu; M Brand; K Zhao; S Huang
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867

Review 3.  Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer.

Authors:  Junan Li; Ming Jye Poi; Ming-Daw Tsai
Journal:  Biochemistry       Date:  2011-06-06       Impact factor: 3.162

4.  FOXP3 can modulate TAL1 transcriptional activity through interaction with LMO2.

Authors:  V Fleskens; M Mokry; A M van der Leun; S Huppelschoten; C E G M Pals; J Peeters; S Coenen; B A Cardoso; J T Barata; J van Loosdregt; P J Coffer
Journal:  Oncogene       Date:  2015-12-21       Impact factor: 9.867

5.  The TAL1/SCL transcription factor regulates cell cycle progression and proliferation in differentiating murine bone marrow monocyte precursors.

Authors:  Soumyadeep Dey; David J Curtis; Stephen M Jane; Stephen J Brandt
Journal:  Mol Cell Biol       Date:  2010-03-01       Impact factor: 4.272

6.  FOXA1 mediates p16(INK4a) activation during cellular senescence.

Authors:  Qian Li; Yu Zhang; Jingxuan Fu; Limin Han; Lixiang Xue; Cuicui Lv; Pan Wang; Guodong Li; Tanjun Tong
Journal:  EMBO J       Date:  2013-02-26       Impact factor: 11.598

Review 7.  Stem Cell Leukemia: how a TALented actor can go awry on the hematopoietic stage.

Authors:  N C Correia; M-L Arcangeli; F Pflumio; J T Barata
Journal:  Leukemia       Date:  2016-06-13       Impact factor: 11.528

8.  MiR-146b negatively regulates migration and delays progression of T-cell acute lymphoblastic leukemia.

Authors:  Nádia C Correia; Rita Fragoso; Tânia Carvalho; Francisco J Enguita; João T Barata
Journal:  Sci Rep       Date:  2016-08-23       Impact factor: 4.379

9.  Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses.

Authors:  Denis Gaucher; René Therrien; Nadia Kettaf; Bastian R Angermann; Geneviève Boucher; Abdelali Filali-Mouhim; Janice M Moser; Riyaz S Mehta; Donald R Drake; Erika Castro; Rama Akondy; Aline Rinfret; Bader Yassine-Diab; Elias A Said; Younes Chouikh; Mark J Cameron; Robert Clum; David Kelvin; Roland Somogyi; Larry D Greller; Robert S Balderas; Peter Wilkinson; Giuseppe Pantaleo; Jim Tartaglia; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  J Exp Med       Date:  2008-12-01       Impact factor: 14.307

10.  Comprehensive functional annotation of seventy-one breast cancer risk Loci.

Authors:  Suhn Kyong Rhie; Simon G Coetzee; Houtan Noushmehr; Chunli Yan; Jae Mun Kim; Christopher A Haiman; Gerhard A Coetzee
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.